NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Return On Equity

Annual ROE:

14.16%+1.48%(+11.67%)
December 31, 2024

Summary

  • As of today, NBIX annual return on equity is 14.16%, with the most recent change of +1.48% (+11.67%) on December 31, 2024.
  • During the last 3 years, NBIX annual ROE has risen by +6.99% (+97.49%).
  • NBIX annual ROE is now -85.03% below its all-time high of 94.61%, reached on December 31, 2011.

Performance

NBIX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXprofitability metrics

Quarterly ROE:

13.35%+1.35%(+11.25%)
June 30, 2025

Summary

  • As of today, NBIX quarterly return on equity is 13.35%, with the most recent change of +1.35% (+11.25%) on June 30, 2025.
  • Over the past year, NBIX quarterly ROE has dropped by -2.09% (-13.54%).
  • NBIX quarterly ROE is now -90.19% below its all-time high of 136.08%, reached on September 30, 2011.

Performance

NBIX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

NBIX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+11.7%-13.5%
3Y3 Years+97.5%+1383.3%
5Y5 Years+113.9%-57.9%

NBIX ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+97.5%-26.6%+224.8%
5Y5-Year-69.3%+113.9%-73.1%+1383.3%
All-TimeAll-Time-85.0%+105.7%-90.2%+103.2%

NBIX ROE History

DateAnnualQuarterly
Jun 2025
-
13.35%(+11.3%)
Mar 2025
-
12.00%(-12.5%)
Dec 2024
14.16%(+11.7%)
13.72%(-15.8%)
Sep 2024
-
16.29%(+5.5%)
Jun 2024
-
15.44%(-15.2%)
Mar 2024
-
18.20%(+38.2%)
Dec 2023
12.68%(+26.4%)
13.17%(+21.3%)
Sep 2023
-
10.86%(+1.1%)
Jun 2023
-
10.74%(+160.0%)
Mar 2023
-
4.13%(-60.2%)
Dec 2022
10.03%(+39.9%)
10.38%(+152.6%)
Sep 2022
-
4.11%(+356.7%)
Jun 2022
-
0.90%(-83.4%)
Mar 2022
-
5.41%(-23.6%)
Dec 2021
7.17%(-84.5%)
7.08%(-81.7%)
Sep 2021
-
38.60%(+11.0%)
Jun 2021
-
34.76%(-19.3%)
Mar 2021
-
43.06%(-13.3%)
Dec 2020
46.20%(+597.9%)
49.68%(+277.2%)
Sep 2020
-
13.17%(-58.5%)
Jun 2020
-
31.73%(+0.8%)
Mar 2020
-
31.47%(+339.5%)
Dec 2019
6.62%(+33.7%)
7.16%(+62.7%)
Sep 2019
-
4.40%(+7.1%)
Jun 2019
-
4.11%(+143.6%)
Mar 2019
-
-9.42%(-282.2%)
Dec 2018
4.95%(+111.9%)
5.17%(+98.8%)
Sep 2018
-
2.60%(+118.1%)
Jun 2018
-
-14.38%(+54.5%)
Mar 2018
-
-31.62%(+27.8%)
Dec 2017
-41.50%(-8.7%)
-43.81%(+27.5%)
Sep 2017
-
-60.41%(+9.9%)
Jun 2017
-
-67.03%(-14.4%)
Mar 2017
-
-58.60%(-56.6%)
Dec 2016
-38.17%(-35.9%)
-37.42%(-20.1%)
Sep 2016
-
-31.17%(-7.8%)
Jun 2016
-
-28.91%(-20.8%)
Mar 2016
-
-23.93%(-9.4%)
Dec 2015
-28.09%(+23.6%)
-21.88%(-1.4%)
Sep 2015
-
-21.58%(-15.6%)
Jun 2015
-
-18.66%(-4.8%)
Mar 2015
-
-17.80%(+39.0%)
Dec 2014
-36.79%(-9.7%)
-29.19%(-8.1%)
Sep 2014
-
-27.01%(+0.0%)
Jun 2014
-
-27.02%(+8.3%)
Mar 2014
-
-29.48%(+12.4%)
Dec 2013
-33.55%(-815.4%)
-33.64%(-83.5%)
Sep 2013
-
-18.33%(-48.1%)
Jun 2013
-
-12.38%(-193.4%)
Mar 2013
-
-4.22%(-208.5%)
Dec 2012
4.69%(-95.0%)
3.89%(+236.5%)
Sep 2012
-
-2.85%(-107.9%)
Jun 2012
-
36.26%(-33.4%)
Mar 2012
-
54.48%(-46.1%)
Dec 2011
94.61%(+238.3%)
101.15%(-25.7%)
Sep 2011
-
136.08%(+147.1%)
Jun 2011
-
55.07%(+173.4%)
Mar 2011
-
20.14%(+134.9%)
DateAnnualQuarterly
Dec 2010
-68.40%(+72.7%)
-57.67%(+68.1%)
Sep 2010
-
-180.78%(+49.8%)
Jun 2010
-
-359.93%(+13.3%)
Mar 2010
-
-414.95%(-11.0%)
Dec 2009
-250.63%(-119.9%)
-373.84%(-32.9%)
Sep 2009
-
-281.26%(-42.7%)
Jun 2009
-
-197.15%(-34.8%)
Mar 2009
-
-146.29%(-31.3%)
Dec 2008
-113.99%(-19.2%)
-111.43%(+28.1%)
Sep 2008
-
-154.95%(-27.4%)
Jun 2008
-
-121.59%(-22.8%)
Mar 2008
-
-99.04%(-18.4%)
Dec 2007
-95.66%(-214.5%)
-83.65%(-157.4%)
Sep 2007
-
-32.50%(+4.0%)
Jun 2007
-
-33.87%(-6.2%)
Mar 2007
-
-31.88%(-5.7%)
Dec 2006
-30.42%(-437.5%)
-30.17%(+3.3%)
Sep 2006
-
-31.19%(-133.3%)
Jun 2006
-
-13.37%(-75.9%)
Mar 2006
-
-7.60%(-32.4%)
Dec 2005
-5.66%(+51.5%)
-5.74%(-18.8%)
Sep 2005
-
-4.83%(+59.3%)
Jun 2005
-
-11.88%(+8.2%)
Mar 2005
-
-12.94%(-15.0%)
Dec 2004
-11.66%(-18.6%)
-11.25%(-107.6%)
Sep 2004
-
-5.42%(+34.4%)
Jun 2004
-
-8.26%(+8.0%)
Mar 2004
-
-8.98%(+15.2%)
Dec 2003
-9.83%(+72.2%)
-10.59%(+62.0%)
Sep 2003
-
-27.85%(+19.9%)
Jun 2003
-
-34.79%(+4.0%)
Mar 2003
-
-36.23%(-4.8%)
Dec 2002
-35.33%(-126.9%)
-34.57%(-26.6%)
Sep 2002
-
-27.30%(-34.3%)
Jun 2002
-
-20.33%(-3.3%)
Mar 2002
-
-19.68%(+2.3%)
Dec 2001
-15.57%(+29.8%)
-20.15%(+4.0%)
Sep 2001
-
-21.00%(+33.2%)
Jun 2001
-
-31.43%(-15.8%)
Mar 2001
-
-27.14%(-9.0%)
Dec 2000
-22.18%(-11.1%)
-24.91%(+10.1%)
Sep 2000
-
-27.71%(-14.1%)
Jun 2000
-
-24.29%(+1.9%)
Mar 2000
-
-24.77%(-5.8%)
Dec 1999
-19.96%(+22.3%)
-23.42%(+19.6%)
Sep 1999
-
-29.13%(-7.6%)
Jun 1999
-
-27.07%(+10.2%)
Mar 1999
-
-30.13%(-17.5%)
Dec 1998
-25.69%(-491.0%)
-25.64%(-55.8%)
Sep 1998
-
-16.46%(-56.6%)
Jun 1998
-
-10.51%(-2665.8%)
Mar 1998
-
-0.38%(-105.9%)
Dec 1997
6.57%(-18.5%)
6.43%(-49.4%)
Sep 1997
-
12.70%(+11.4%)
Jun 1997
-
11.40%(-29.1%)
Mar 1997
-
16.08%(+59.2%)
Dec 1996
8.06%
10.10%(+287.0%)
Sep 1996
-
2.61%(-32.7%)
Jun 1996
-
3.88%

FAQ

  • What is Neurocrine Biosciences, Inc. annual return on equity?
  • What is the all-time high annual ROE for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual ROE year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly ROE year-on-year change?

What is Neurocrine Biosciences, Inc. annual return on equity?

The current annual ROE of NBIX is 14.16%

What is the all-time high annual ROE for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual return on equity is 94.61%

What is Neurocrine Biosciences, Inc. annual ROE year-on-year change?

Over the past year, NBIX annual return on equity has changed by +1.48% (+11.67%)

What is Neurocrine Biosciences, Inc. quarterly return on equity?

The current quarterly ROE of NBIX is 13.35%

What is the all-time high quarterly ROE for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly return on equity is 136.08%

What is Neurocrine Biosciences, Inc. quarterly ROE year-on-year change?

Over the past year, NBIX quarterly return on equity has changed by -2.09% (-13.54%)
On this page